HIGHLIGHTS
SUMMARY
In a multi-center study including 17 U.S.-based hospitals, it was concluded that patients undergoing MI-AVR compared to C-AVR were three times more frequently discharged by the fourth postoperative day, and fewer MI-AVR patients received a blood product transfusion (24.6% vs. 31.8%). Similarly, in the study, when the authors compared total hospital costs and outcomes of C-AVR and MIAVR, the authors found that there was a slight advantage in the MI-AVR approach with regard to overall efficacy as well as a decreased total hospital cost . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.